Estrogen Receptor α and Aryl Hydrocarbon Receptor Cross-talk in a Transfected Hepatoma Cell Line (HepG2) Exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Overview

Journal Toxicol Rep

Date 2017 Oct 1

PMID 28962316

Citations 13

Authors

Manuela Gottel

Ludovic Le Corre

Coralie Dumont

Dieter Schrenk

Marie-Christine Chagnon

Affiliations

Soon will be listed here.

Abstract

The prototype dioxin congener 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is known to exert anti-estrogenic effects activation of the aryl hydrocarbon receptor (AhR) by interfering with the regulation of oestrogen homeostasis and the estrogen receptor α (ERα) signalling pathway. The AhR/ER cross-talk is considered to play a crucial role in TCDD- and E2-dependent mechanisms of carcinogenesis, though the concerted mechanism of action in the liver is not yet elucidated. The present study investigated TCDD's impact on the transcriptional cross-talk between AhR and ERα and its modulation by 17β-estradiol (E2) in the human hepatoma cell line HepG2, which is AhR-responsive but ERα-negative. Transient transfection assays with co-transfection of hERα and supplementation of receptor antagonists showed anti-estrogenic action of TCDD down-regulation of E2-induced ERα signaling. In contrast, enhancement of AhR signaling dependent on ERα was observed providing evidence for increased cytochrome P450 (CYP) induction to promote E2 metabolism. However, relative mRNA levels of major E2-metabolizing CYP1A1 and 1B1 and the main E2-detoxifying catechol-O-methyltransferase were not affected by the co-treatments. This study provides new evidence of a TCDD-activated AhR-mediated molecular AhR/ERα cross-talk mechanism at transcriptional level indirect inhibition of ERα and enhanced transcriptional activity of AhR in HepG2 cells.

Citing Articles

The Aryl Hydrocarbon Receptor and Its Crosstalk: A Chemopreventive Target of Naturally Occurring and Modified Phytochemicals.

Szaefer H, Licznerska B, Baer-Dubowska W Molecules. 2024; 29(18).

PMID: 39339278 PMC: 11433792. DOI: 10.3390/molecules29184283.

Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.

Barata I, Rueff J, Kranendonk M, Esteves F J Xenobiot. 2024; 14(2):575-603.

PMID: 38804287 PMC: 11130977. DOI: 10.3390/jox14020034.

Menopause Hot Flashes and Molecular Mechanisms Modulated by Food-Derived Nutrients.

Forma E, Urbanska K, Brys M Nutrients. 2024; 16(5).

PMID: 38474783 PMC: 10935406. DOI: 10.3390/nu16050655.

The role of the aryl hydrocarbon receptor in mediating the effects of mono(2-ethylhexyl) phthalate in mouse ovarian antral follicles†.

Neff A, Inman Z, Mourikes V, Santacruz-Marquez R, Gonsioroski A, Laws M Biol Reprod. 2023; 110(3):632-641.

PMID: 38134965 PMC: 10993471. DOI: 10.1093/biolre/ioad178.

Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review).

Chen C, Wang Z, Liao Z, Zhang Y, Lei W, Shui X Mol Med Rep. 2023; 29(1).

PMID: 37997818 PMC: 10704547. DOI: 10.3892/mmr.2023.13134.

References

Knerr S, Schrenk D . Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models. Mol Nutr Food Res. 2006; 50(10):897-907. DOI: 10.1002/mnfr.200600006. View

Beischlag T, Perdew G . ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J Biol Chem. 2005; 280(22):21607-11. DOI: 10.1074/jbc.C500090200. View

Swedenborg E, Pongratz I . AhR and ARNT modulate ER signaling. Toxicology. 2009; 268(3):132-8. DOI: 10.1016/j.tox.2009.09.007. View

Matthews J, Wihlen B, Thomsen J, Gustafsson J . Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol. 2005; 25(13):5317-28. PMC: 1156992. DOI: 10.1128/MCB.25.13.5317-5328.2005. View

Gierthy J, Lincoln D, Gillespie M, Seeger J, Martinez H, DICKERMAN H . Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 1987; 47(23):6198-203. View

Lucier G, Tritscher A, Goldsworthy T, Foley J, Clark G, Goldstein J . Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 1991; 51(5):1391-7. View

Merchant M, Arellano L, Safe S . The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Arch Biochem Biophys. 1990; 281(1):84-9. DOI: 10.1016/0003-9861(90)90416-v. View

Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M, Safe S . Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Endocrinol. 1999; 13(9):1511-21. DOI: 10.1210/mend.13.9.0338. View

Safe S . Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett. 2001; 120(1-3):1-7. DOI: 10.1016/s0378-4274(01)00301-0. View

10.

Wang W, Smith 3rd R, Safe S . Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes. Arch Biochem Biophys. 1998; 356(2):239-48. DOI: 10.1006/abbi.1998.0782. View

11.

Zacharewski T, Bondy K, McDonell P, Wu Z . Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Res. 1994; 54(10):2707-13. View

12.

Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T . Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch Toxicol. 2002; 76(5-6):287-98. DOI: 10.1007/s00204-002-0340-z. View

13.

Rossini G, Baldini G, Villa E, Manenti F . Characterization of estrogen receptor from human liver. Gastroenterology. 1989; 96(4):1102-9. DOI: 10.1016/0016-5085(89)91629-6. View

14.

Baumgart A, Schmidt M, Schmitz H, Schrenk D . Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. Biochem Pharmacol. 2005; 69(4):657-67. DOI: 10.1016/j.bcp.2004.11.017. View

15.

Rogan E, Badawi A, Devanesan P, Meza J, Edney J, West W . Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis. 2003; 24(4):697-702. DOI: 10.1093/carcin/bgg004. View

16.

. Polychlorinated Dibenzo-Para-Dioxins and Polychlorinated Dibenzofurans. IARC Monogr Eval Carcinog Risks Hum. 1997; 69:1-631. PMC: 5366851. View

17.

Matthews J, Gustafsson J . Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl Recept Signal. 2006; 4:e016. PMC: 1513070. DOI: 10.1621/nrs.04016. View

18.

MacPherson L, Lo R, Ahmed S, Pansoy A, Matthews J . Activation function 2 mediates dioxin-induced recruitment of estrogen receptor alpha to CYP1A1 and CYP1B1. Biochem Biophys Res Commun. 2009; 385(2):263-8. DOI: 10.1016/j.bbrc.2009.05.060. View

19.

Lu F, Zahid M, Saeed M, Cavalieri E, Rogan E . Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol. 2007; 105(1-5):150-8. PMC: 1986824. DOI: 10.1016/j.jsbmb.2006.12.102. View

20.

Liu S, Abdelrahim M, Khan S, Ariazi E, Jordan V, Safe S . Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol Chem. 2006; 387(9):1209-13. DOI: 10.1515/BC.2006.149. View